Latest California Healthline Stories
KHN senior correspondent Christina Jewett describes the obstacles facing workers and their families trying to secure death benefits or workers’ compensation after COVID-19 struck.
Additional guidance issued late last month by the Trump administration added to the confusion. Some consumers may find themselves unexpectedly on the hook for the cost of a test.
KHN’s Midwest correspondent Lauren Weber drills through the vital health care policy stories of the week, so you don’t have to.
Half the states are rolling back strict policies that have kept family members out of nursing homes because of fears of spreading the coronavirus.
KHN executive editor Damon Darlin wades through mounds of health care policy stories — so you don’t have to.
While COVID-19 cases continue to surge in more than half the country, the Trump administration has decided its top priority is for schools to open for in-person learning this fall. Meanwhile, the Supreme Court hands Trump a victory in a case to limit the reach of the birth control benefit under the Affordable Care Act. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Sarah Varney about the latest KHN-NPR “Bill of the Month.”
The delays can be excruciating, with some extreme cases running more than 20 days. People getting tested at urgent care centers, community health centers, pharmacies and state-run drive-thru or walk-up sites are often waiting a week or more to find out if they tested positive for the coronavirus.
Unlike earlier in the year, most hospitals are not proactively canceling elective surgeries, even in some places seeing spikes in coronavirus patients.
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
Public health authorities had hoped digital technology would supplement the work of contact tracers seeking to control the spread of COVID-19. But technical uncertainties and public health failures have dimmed the apps’ potential.